These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7399856)

  • 21. Primary hyperparathyroidism with carcinoma of the right breast--a case report.
    Muin IA; Meah FA
    Med J Malaysia; 1994 Sep; 49(3):301-2. PubMed ID: 7845286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypercalcemia due to parathyroid adenoma without associated malignant neoplasms].
    Fantesini C; Rossi F; Cremaschi S; Tumiati B; Portioli I; Davoli V; Brini M
    G Clin Med; 1980 Jul; 61(7):535-44. PubMed ID: 7450369
    [No Abstract]   [Full Text] [Related]  

  • 23. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC; Schfirin BS
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late manifestations of breast cancer.
    Segaloff A
    Med Clin North Am; 1967 Jul; 51(4):1089-91. PubMed ID: 6028190
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment and treatment considerations in a patient with advanced breast cancer and acute intermittent porphyria.
    Kristiansen C; Langkjer ST
    Acta Oncol; 2006; 45(3):337-9. PubMed ID: 16644579
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of using Aredia for hypercalcemia in oncology patients].
    Lichinitser MR; Vyshinskaia GV; Kupchan DZ; Liubimova NV
    Ter Arkh; 1993; 65(9):80-1. PubMed ID: 8303606
    [No Abstract]   [Full Text] [Related]  

  • 27. Altered calcium metabolism.
    Held-Warmkessel J
    Clin J Oncol Nurs; 2000; 4(3):139-40. PubMed ID: 11235253
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hematological manifestations of cancer of the breast].
    Giard P; Duhamel M; Croccel L; Cousin P
    J Sci Med Lille; 1965 Dec; 83(12):677-82. PubMed ID: 5857621
    [No Abstract]   [Full Text] [Related]  

  • 29. [Association of diffuse breast cancer and malignant lymphoma of the colon].
    Simonov NN; Leonenkov VV; Riazankina AA; Kovalëv VK; Makeeva TK; El'tsin SS
    Vestn Khir Im I I Grek; 1997; 156(6):63-4. PubMed ID: 9505392
    [No Abstract]   [Full Text] [Related]  

  • 30. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expanding the possibilities of using biphosphonates for prophylaxis and treatment of osteal complications in malignant metastasis].
    Svishchenko IuA; Shimanovskiĭ NL
    Eksp Klin Farmakol; 2004; 67(6):66-71. PubMed ID: 15707020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI).
    Yost KJ; Yount SE; Eton DT; Silberman C; Broughton-Heyes A; Cella D
    Breast Cancer Res Treat; 2005 Apr; 90(3):295-8. PubMed ID: 15830143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant eccrine poroma in breast cancer-related lymphoedema.
    Lynch MD; Jones AE; Marker A; Grant JW; Purushotham AD
    Ann R Coll Surg Engl; 2004 Nov; 86(6):W32-5. PubMed ID: 16749962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatitis, hypercalcemia, and breast carcinoma.
    Clark OH
    JAMA; 1976 Nov; 236(18):2052. PubMed ID: 989785
    [No Abstract]   [Full Text] [Related]  

  • 35. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I; Kousidou OCh; Karamanos NK
    In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
    Ito K; Ito T; Okada T; Watanabe T; Gomi K; Kanai T; Mochizuki Y; Amano J
    Breast J; 2009; 15(4):435-7. PubMed ID: 19470131
    [No Abstract]   [Full Text] [Related]  

  • 38. [Malignant hypercalcemia with and without bone metastasis].
    Millán Núñez-Cortés J; de Moneo González A
    Rev Clin Esp; 1996 Jun; 196(6):388-91. PubMed ID: 8767075
    [No Abstract]   [Full Text] [Related]  

  • 39. [Metastasis from an epithelioma of the breast at the level of a middle ear glomic formation].
    Wayoff M; Rauber G; Labaeye P
    Rev Otoneuroophtalmol; 1966; 38(2):81-6. PubMed ID: 5931087
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of obesity on breast cancer receptor status and prognosis.
    Rose DP; Vona-Davis L
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1091-101. PubMed ID: 19671029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.